MABVAX THERAPEUTICS HOLDINGS, INC. S-8, filed Dec 21, 2017: OPINION ON LEGALITY
Exhibit
5.1

December 20,
2017
MabVax
Therapeutics Holdings, Inc.
11535
Sorrento Valley Road, Suite 400
San
Diego, California 92121
Re: Registration Statement
on Form S-8
Ladies and Gentlemen:
We have acted as counsel in connection with the
preparation and filing of that certain Registration Statement on
Form S-8 (the “Registration Statement”) filed by
MabVax Therapeutics Holdings, Inc., a
Delaware corporation, (the “Company”) with the
Securities and Exchange Commission (the “Commission”)
under the Securities Act of 1933, as amended (the
“Act”), in connection with the registration of
8,998,569 additional shares of the Company’s common stock
(the “Shares”), under the Company’s Fifth
Amended and Restated MabVax Therapeutics Holdings, Inc. 2014
Employee, Director and Consultant Equity Incentive Plan
(the
“Plan”).
We
have examined and reviewed only such documents, records and matters
of law as we have deemed necessary or appropriate for the purpose
of rendering the opinion set forth herein. Insofar as the opinion
set forth herein is based on factual matters in connection with,
among other things, the issuance of the Shares, which factual
matters are authenticated in certificates from certain officers of
the Company, we have relied on such certificates. We have assumed
the genuineness of all signatures, the authenticity of all
documents submitted to us as originals and the conformity to
originals of all documents submitted to us as certified or
reproduced copies.
Based
upon the foregoing and subject to the assumptions, limitations and
exceptions set forth herein, we are of the opinion that as of the
date hereof, the Shares have been duly authorized and, when issued
and delivered against payment therefor in conformity with the terms
of the Plan, will be validly issued, fully paid and
non-assessable.
We express no opinion as to the applicability or
effect of any laws, orders or judgments of any state or other
jurisdiction other than the General Corporation Law of the State of
Delaware (including the statutory provisions and all applicable
provisions of the Delaware Constitution and reported judicial decisions interpreting those
laws), and the federal securities laws. Further, this opinion is
based solely upon existing laws, rules and regulations, and we
undertake no obligation to advise you of any changes that may be
brought to our attention after the date hereof. This opinion is
expressly limited to the matters set forth above and we render no
opinion, whether by implication or otherwise, as to any other
matters relating to the Company, the Registration Statement or the
Shares.
This
opinion is issued to you solely for use in connection with the
Registration Statement and is not to be quoted or otherwise
referred to in any financial statements of the Company or any other
document, nor is it to be filed with or furnished to any government
agency or other person, without our prior written
consent.
We
hereby consent to the use of this opinion as Exhibit 5.1 to the
Registration Statement. In giving this consent, we do not admit
that we are within the category of persons whose consent is
required under Section 7 of the Act or the rules and
regulations of the Commission adopted under the Act.
1185
Avenue of the Americas |
37th Floor
| New York, NY | 10036
T (212)
930 9700 | F (212) 930 9725
| WWW.SRFKLLP.COM